[1]
|
B. Glasson, A. Benakis and M. Thomasset, “Localisation, Distribution, Excretion et Metabolisme d’eun Nouveau Medicament Anorexigene Marqué au C14: Le Cholhydrate de Clobenzorex,” Arzneim-Forsch, Vol. 21, 1971, pp. 1985-1992.
|
[2]
|
S. Valtier and J. T. Cody, “Differentiation of Clobenzorex Use from Amphetamine Abuse Using the Metabolite 4-Hydroxyclobenzorex,” Journal of Analytical Toxicology, Vol. 24, No. 7, 2000, pp. 606-613.
doi:10.1093/jat/24.7.606
|
[3]
|
K. L. Baden, S. Valtier and J. T. Cody, “Metabolic Production of Amphetamine Following Multidose Administration of Clobenzorex,” Journal of Analytical Toxicology, Vol. 23, No. 6, 1999, pp. 511-517.
doi:10.1093/jat/23.6.511
|
[4]
|
J. T. Cody and S. Valtier, “A Gas Chromatography-Mass Spectrometry Method for the Quantitation of Clobenzorex,” Journal of Analytical Toxicology, Vol. 23, 1999, pp. 603-608.
|
[5]
|
Goodman and Gilman, “Las Bases Farmacológicas de la Terapéutica,” Décima Edición, McGraw Hill, New York, 2006, pp. 223-275.
|
[6]
|
M. Rowland and T. N. Tozer, “Clinical Pharmacokinetics. Concepts and Applications,” 3rd Edition, Lea & Febiger, Philadelphia, London, 1995.
|